Article Details

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Consensus Rating of "Buy" by Brokerages

Retrieved on: 2020-12-07 06:47:21

Tags for this article:

Click the tags to see associated articles and topics

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Consensus Rating of "Buy" by Brokerages. View article details on hiswai:

Excerpt

<b>Man Group plc</b> now owns 257,346 shares of the company's stock worth $8,405,000 after purchasing an additional 244,384 shares during the period.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up